Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07056283 · ClinicalTrials.gov registry record
The Study of Urinary Biomarkers in Patients With Hypomagnesemia
A clinical trial of Hypomagnesemia, sponsored by University of Florida.
- Recruiting
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT07056283 is a study of Hypomagnesemia that is actively recruiting participants, run by University of Florida. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07056283, a study of Hypomagnesemia, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
In this pilot exploratory study, we aim to examine extracellular vesicles (EVs) as biomarkers in urine from up to 15 patients, with up to 10 samples per patient among the patients with a history of hypomagnesemia.
Conditions Studied
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-07-31 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07056283
The ClinicalTrials.gov registry entry for NCT07056283 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypomagnesemia appearing as the primary indexed condition, and to 0 interventions.
NCT07056283 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07056283 about?
NCT07056283 is a clinical study titled "The Study of Urinary Biomarkers in Patients With Hypomagnesemia". In this pilot exploratory study, we aim to examine extracellular vesicles (EVs) as biomarkers in urine from up to 15 patients, with up to 10 samples per patient among the patients with a history of hypomagnesemia.
What is the current status of trial NCT07056283?
This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2025-07-31. Estimated completion is 2027-06.
What conditions does trial NCT07056283 study?
This clinical trial studies the following conditions: Hypomagnesemia.
Who is sponsoring clinical trial NCT07056283?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07056283 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypomagnesemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.